News and Insights

Featured

Numerof State of Population Health Survey

Population health management has been a national topic of conversation, but to date little effort has been devoted to tracking the actual progress that’s been made toward this new model of care. Now in its sixth year, Numerof’s State of Population Health survey provides an in-depth, national look at the…

New Commercial Models for the New Hospital Customer

MD&DI

Facing lower reimbursements and growing demands for price transparency, hospitals are demanding more evidence of differentiated value as they select medical device products.  Moreover, hospitals are seeking performance guarantees and other risk-sharing arrangements in the hopes that they can offset the financial risks they are assuming by adopting population health…

Defining the Job Description for Population Health

Modern Healthcare

The term population health is being used everywhere, and it means different things to different people… even on the same executive team. Many organizations try to develop a “population health strategy” without fully understanding what it means, and are turning to their physician leaders to take charge. Physician leaders who…

Changing Payer Perspectives on Market Access Across the G-5

eyeforpharma

It was less than a decade ago that most pharmaceutical manufacturers considered market access the last step in the commercialization process… maybe even something that happened post-launch! However it has become increasingly clear that this approach must change. Companies exploring opportunities in global markets face dynamic demographic and disease trends,…

Diagnosing and Treating Readmissions

H&HN

Hospital readmissions arguably are one of the biggest clinical issues facing healthcare systems today.  Otherwise known as “bouncebacks”, readmissions have proven to be extremely costly, and are taken as a concrete metric of inadequate quality.  According to a September 19, 2013 study in The New England Journal of Medicine, nearly…